Clinical Trials Browser

Phase 2 × Triple-negative Metastatic Breast Cancer × adavosertib × Clear all

NCT03012477 2021-11-23

CISPLATIN + AZD-1775 In Breast Cancer

Phase 2 Completed

34 enrolled 9 charts

Triple-negative Metastatic Breast Cancer